
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,600 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 218 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications”, Eur J Clin Pharmacol, vol. 70, pp. 849-57, 2014.
, “Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project”, Curr Clin Pharmacol, vol. 9, pp. 130-8, 2014.
, “Sex- and age-specific incidence of fractures in mental illness: a historical, population-based cohort study”, J Clin Psychiatry, vol. 69, pp. 1398-403, 2008.
, “Prevalence of maternal mental illness among children and adolescents in the UK between 2005 and 2017: a national retrospective cohort analysis”, Lancet Public Health, vol. 4, pp. e291-e300, 2019.
, “Effect of Cesarean Delivery on Long-term Risk of Small Bowel Obstruction”, Obstet Gynecol, vol. 131, pp. 354-359, 2018.
, “Antibiotic use and the risk of flare of inflammatory bowel disease”, Clin Gastroenterol Hepatol, vol. 3, pp. 459-65, 2005.
, “Risk for active tuberculosis in inflammatory bowel disease patients”, Clin Gastroenterol Hepatol, vol. 5, pp. 1070-5, 2007.
, “Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from Clinical Practice Research Datalink”, Rheumatology (Oxford), vol. 57, pp. 977-981, 2018.
, “Rheumatoid arthritis is getting less frequent-results of a nationwide population-based cohort study”, Rheumatology (Oxford), vol. 56, pp. 736-744, 2017.
, “Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study”, Bmj, vol. 360, p. k872, 2018.
, “Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes”, Epidemiology, vol. 29, pp. 246-253, 2018.
, “Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study”, Bmj, vol. 363, p. k4880, 2018.
, “The Association between Oral Anticoagulants and Cancer Incidence among Individuals with Nonvalvular Atrial Fibrillation”, Thromb Haemost, 2020.
, “Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes”, Diabetes Care, vol. 42, pp. e150-e152, 2019.
, “Trends in acid suppressant drug prescriptions in primary care in the UK: a population-based cross-sectional study”, BMJ Open, vol. 10, p. e041529, 2020.
, “The Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic Fracture in the United Kingdom: Population-Based Cohort Study”, J Am Med Dir Assoc, 2019.
, “Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study”, Ann Rheum Dis, 2020.
, “Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K”, Br J Dermatol, vol. 163, pp. 586-92, 2010.
, “Peripartum hysterectomy: an economic analysis of direct healthcare costs using routinely collected data”, Bjog, vol. 125, pp. 874-883, 2018.
, “Prioritizing children's medicines for research: a pharmaco-epidemiological study of antiepileptic drugs”, Br J Clin Pharmacol, vol. 63, pp. 689-97, 2007.
, “Changing trends in antiepileptic drug prescribing in girls of child-bearing potential”, Arch Dis Child, vol. 94, pp. 443-7, 2009.
, “Mortality rates and causes of death in children with epilepsy prescribed antiepileptic drugs: a retrospective cohort study using the UK General Practice Research Database”, Drug Saf, vol. 34, pp. 403-13, 2011.
, “The risk of venous thromboembolism after surgery for esophagogastric malignancy and the impact of chemotherapy: a population-based cohort study”, Dis Esophagus, 2019.
, “A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction”, Eur J Clin Pharmacol, vol. 72, pp. 1105-16, 2016.
, “Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use”, Br J Clin Pharmacol, vol. 84, pp. 776-785, 2018.
, “Risk of adverse outcomes following urinary tract infection in older people with renal impairment: Retrospective cohort study using linked health record data”, PLoS Med, vol. 15, p. e1002652, 2018.
, “Antibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract infection: cohort study”, Age Ageing, vol. 48, pp. 228-234, 2019.
, “Medication Use Quality and Safety in Older Adults: 2018 Update”, J Am Geriatr Soc, 2019.
, “Hormone replacement therapy and cataract: a population-based case-control study”, Eye (Lond), vol. 20, pp. 417-22, 2006.
, “Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease”, Heart, 2019.
, “Performance and clinical utility of supervised machine-learning approaches in detecting familial hypercholesterolaemia in primary care”, NPJ Digit Med, vol. 3, p. 142, 2020.
, “Health checks and cardiovascular risk factor values over six years' follow-up: Matched cohort study using electronic health records in England”, PLoS Med, vol. 16, p. e1002863, 2019.
, “Oral bisphosphonate use and all-cause mortality in patients with moderate-severe (grade 3B-5D) chronic kidney disease: a population-based cohort study”, J Bone Miner Res, 2020.
, “Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly-diagnosed type 2 diabetes and early glycemic control”, Curr Med Res Opin, vol. 34, pp. 337-343, 2018.
, “Impact of bleeding complications on length of stay and critical care utilization in cardiac surgery patients in England”, J Cardiothorac Surg, vol. 14, p. 64, 2019.
, “Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study”, Inflamm Bowel Dis, vol. 23, pp. 672-680, 2017.
, “Smoking Status at Diagnosis and Subsequent Smoking Cessation: Associations With Corticosteroid Use and Intestinal Resection in Crohn's Disease”, Am J Gastroenterol, vol. 113, pp. 1689-1700, 2018.
, “Population prevalence of Down's syndrome in the United Kingdom”, J Intellect Disabil Res, vol. 60, pp. 874-8, 2016.
, “Morbidity and medication in a large population of individuals with Down syndrome compared to the general population”, Dev Med Child Neurol, vol. 58, pp. 246-54, 2016.
, “Statin use is associated with reduced risk of histologic subtypes of esophageal cancer: a nested case-control analysis”, Gastroenterology, vol. 146, pp. 661-8, 2014.
, “Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study”, Gastroenterology, vol. 150, pp. 854-65.e1; quiz e16-7, 2016.
, “Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study”, Eur J Gastroenterol Hepatol, vol. 25, pp. 15-21, 2013.
, “Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink”, Value Health, vol. 18, pp. 260-70, 2015.
, “Risk of Recurrent Bleeding Events in Nonvalvular Atrial Fibrillation Treated with Vitamin K Antagonists: A Clinical Practice Research Datalink Study”, TH Open, vol. 3, pp. e316-e324, 2019.
, “Impact of atrial fibrillation awareness campaigns: interrupted time series using the Clinical Practice Research Datalink”, Future Cardiol, 2019.
, “The impact of regulatory action on the co-prescribing of renin-angiotensin system blockers in UK primary care”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 858-862, 2017.
, “Recent use of oral contraceptives and the risk of multiple sclerosis”, Arch Neurol, vol. 62, pp. 1362-5, 2005.
, “Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis”, Neurology, vol. 66, pp. 572-5, 2006.
, “Antibiotic use and risk of multiple sclerosis”, Am J Epidemiol, vol. 163, pp. 997-1002, 2006.
, “Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort”, J Neurol, vol. 254, pp. 1736-41, 2007.
,